Author： Comets Emmanuelle Zohar Sarah
Publisher： Adis International
ISSN： 0312-5963
Source： Clinical Pharmacokinetics, Vol.48, Iss.6, 2009-06, pp. : 387-395
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
An Adaptive Design for Phase II Non-Oncology Dose Selection Clinical Trials
By Su Zheng
Clinical Drug Investigation, Vol. 30, Iss. 6, 2010-06 ,pp. :
Access to resources
Recommend
Phase I oncology trials: risks and benefits vary by trial type
Reactions Weekly, Vol. 1, Iss. 1042, 2005-01 ,pp. :
Phase I oncology trials: risks and benefits vary by trial type
Inpharma, Vol. 1, Iss. 1478, 2005-01 ,pp. :
Ethical Issues in Phase I Cancer Clinical Trials
International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. :